About the Fertility Treatment Industry

Fertility treatment is a medical field whose importance has been increasing globally, driven by structural social changes such as declining birth rates and later marriage.

Assisted Reproductive Technology (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo cryopreservation, has evolved as a treatment approach that supports people wishing to conceive through advanced medical technologies.

Fertility treatment is a critical medical field that is closely linked to individuals’ life planning and family formation, while also influencing the sustainability of society as a whole. Accordingly, there is a strong demand for the provision of medical care that ensures high levels of safety, ethical standards, and reproducibility.

Business Environment Surrounding the Fertility Treatment Industry

Due to later marriage and the increase in childbirth at older ages, demand for fertility treatment is expanding both domestically and internationally.

In Japan, public support for fertility treatment has been expanded, leading to improved access to treatment and greater social understanding. At the same time, the industry as a whole faces challenges that must be addressed, including improving treatment outcomes, reducing the burden on healthcare professionals, and establishing stable medical care delivery systems.

Technological Innovation and Quality Requirements

In fertility treatment, extremely delicate cells such as oocytes, sperm, and embryos are handled; therefore, the quality of medical devices, culture media, and cryopreservation technologies used has a significant impact on treatment outcomes.

As a result, products and technologies that comply with international standards, ensure high reproducibility and safety, and offer ease of use in clinical settings are indispensable.

Progress of Globalization

The fertility treatment industry is a global industry that transcends national borders, with research findings and treatment technologies being shared internationally and contributing to improvements in medical standards across countries.

At the same time, there is a growing need to establish quality assurance systems and stable supply structures that comply with the regulatory requirements of each country.

Future Outlook

Looking ahead, the fertility treatment industry is expected to continue evolving in multiple areas, including improved treatment outcomes, reduced patient burden, and enhanced working environments for healthcare professionals, driven by ongoing technological innovation and growing social demand.
As a form of medical care that supports “the lives of the future,” the social value of fertility treatment is expected to continue to increase.

The Role of Kitazato Corporation

As a company supporting the development of the fertility treatment industry, Kitazato Corporation provides products and technologies that support the entire reproductive medicine process, from oocyte retrieval, fertilization, culture, and cryopreservation to embryo transfer.
By developing products with high quality and reproducibility, implementing quality assurance systems based on international standards, and leveraging the experience and trust cultivated in more than 110 countries worldwide, we contribute to addressing clinical challenges and improving treatment outcomes.
Kitazato Corporation will continue to grow alongside the fertility treatment industry and, as a company that supports the beginning of life, will remain close to medical institutions and patients worldwide while contributing to the realization of sustainable healthcare and society.